Have no fear, the COVID vaccine is safe

2021-01-14T15:05:43-06:00

Recently, HAE International's President and CEO, Tony Castaldo interviewed Prof. Dr. Marcus Maurer to discuss HAE patients and the COVID vaccine. We encourage everyone to please watch this short video that discusses how having HAE

Have no fear, the COVID vaccine is safe2021-01-14T15:05:43-06:00

TAKHZYRO Now Available in Alberta

2020-12-04T15:46:17-06:00

We are thrilled to share that as of December 1st, 2020, Type I & II HAE patients in Alberta have access to lanadelumab (Takhzyro) through the province's Drug Benefit List. Alberta is the first province

TAKHZYRO Now Available in Alberta2020-12-04T15:46:17-06:00

TAKHZYRO: One Step Closer

2020-11-20T15:50:43-06:00

Amazing news! Canadian HAE patients are one step closer to gaining equitable access to the new treatment, TAKHZYRO! After months of negotiations, Takeda Canada announced it has completed negotiations with the pan Canadian Pharmaceutical Alliance (pCPA)

TAKHZYRO: One Step Closer2020-11-20T15:50:43-06:00

Terrific News for HAE Patients in Quebec

2020-08-12T07:27:46-06:00

We have some exciting news to share! We are pleased to let everyone know the Institut national d’excellence en santé et en services sociaux (INESSS) has reevaluated lanadelumab (Takhzyro) and soon HAE patients in Quebec

Terrific News for HAE Patients in Quebec2020-08-12T07:27:46-06:00
Go to Top